Jorge Calderón‐Parra

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID

Jorge Calderón‐Parra, Antonio Muiño-Míguez, Alejandro David Bendala Estrada et al. · PLoS ONE · 2021 · 120 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +11

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

C. Avendaño, António Ramos, Elena Múñez et al. · Journal of Clinical Investigation · 2021 · 110 citations · Full text

Life Sciences, Immunology, Infectious Diseases +7

Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies

Jorge Calderón‐Parra, Elena Múñez, Ana Fernández‐Cruz et al. · Clinical Infectious Diseases · 2021 · 81 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Red blood cell distribution width as prognostic factor in sepsis: A new use for a classical parameter

Víctor Moreno‐Torres, Ana Royuela, Elena Múñez et al. · Journal of Critical Care · 2022 · 52 citations · Full text

Veterinary Medicine, Biostatistics, Internal Medicine +17